Virginia Tech: Academic-Private Partnership Aims to Reduce Toxic Effects of Deadly Digestive Bacteria
August 09, 2023
August 09, 2023
BLACKSBURG, Virginia, Aug. 9 -- Virginia Tech issued the following news:
The bacterium commonly referred to as C. diff is sometimes called "C-difficult" because it is so hard to treat, said Mohamed Seleem, director of the Center for One Health Research.
Seleem and Nectagen Inc. have received a nearly $275,000 grant from the National Institute of Allergy and Infectious Diseases to study whether synthetic proteins developed by Nectagen can reduce the toxicity of . . .
The bacterium commonly referred to as C. diff is sometimes called "C-difficult" because it is so hard to treat, said Mohamed Seleem, director of the Center for One Health Research.
Seleem and Nectagen Inc. have received a nearly $275,000 grant from the National Institute of Allergy and Infectious Diseases to study whether synthetic proteins developed by Nectagen can reduce the toxicity of . . .